Estrogen directly activates AID transcription and function

Journal of Experimental Medicine

Volumn 206, Issue 1, 2009, Pages 99-111

  Pauklin, Siim ^a   Sernández, Isora V ^b   Bachmann, Gudrun ^a,c   Ramiro, Almudena R ^b   Petersen Mahrt, Svend K ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3B; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; DEAMINASE; ESTROGEN; ESTROGEN RECEPTOR; HYDROLASE; IMMUNOGLOBULIN; MESSENGER RNA; TAMOXIFEN; UNCLASSIFIED DRUG; AICDA (ACTIVATION INDUCED CYTIDINE DEAMINASE); AICDA (ACTIVATION-INDUCED CYTIDINE DEAMINASE); APOBEC3 PROTEIN, HUMAN; APOBEC3 PROTEIN, MOUSE; CYTIDINE DEAMINASE; CYTOSINE DEAMINASE; ESTROGEN RECEPTOR ALPHA; FAS ANTIGEN; ONCOPROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CARCINOGENESIS; CONTROLLED STUDY; ENZYME SYNTHESIS; FEMALE; GENE EXPRESSION; GENE LOCUS; GENE TRANSLOCATION; GENETIC RECOMBINATION; GENOTOXICITY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SOMATIC HYPERMUTATION; ANIMAL; B LYMPHOCYTE; BAGG ALBINO MOUSE; CELL CULTURE; CELL LINE; CYTOLOGY; DNA RESPONSIVE ELEMENT; DRUG EFFECT; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MUTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD95; B-LYMPHOCYTES; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; CYTIDINE DEAMINASE; CYTOSINE DEAMINASE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; MICE; MICE, INBRED BALB C; MUTATION; ONCOGENE PROTEINS, FUSION; PROTEIN BINDING; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; TRANSCRIPTION, GENETIC;

EID: 60549115641     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20080521     Document Type: Article

References (72)

1. Neuberger, M.S., R.S. Harris, J. Di Noia, and S.K. Petersen-Mahrt. 2003. Immunity through DNA deamination. Trends Biochem. Sci. 28: 305-312.
2. Arakawa, H., J. Hauschild, and J.M. Buerstedde. 2002. Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion. Science. 295:1301-1306.
3. Harris, R.S., J.E. Sale, S.K. Petersen-Mahrt, and M.S. Neuberger. 2002. AID is essential for immunoglobulin V gene conversion in a cultured B cell line. Curr. Biol. 12:435-438.
4. Muramatsu, M., K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 102:553-563.
5. Muramatsu, M., V.S. Sankaranand, S. Anant, M. Sugai, K. Kinoshita, N.O. Davidson, and T. Honjo. 1999. Specific expression of activation- induced cytidine deaminase (AID), a novel member of the RNA-edit-ing deaminase family in germinal center B cells. J. Biol. Chem. 274: 18470-18476.
6. Chaudhuri, J., and F.W. Alt. 2004. Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat. Rev. Immunol. 4:541-552.
7. Di Noia, J.M., and M.S. Neuberger. 2007. Molecular mechanisms of antibody somatic hypermutation. Annu. Rev. Biochem. 76:1-22.
8. Petersen-Mahrt, S. 2005. DNA deamination in immunity. Immunol. Rev. 203:80-97.
9. Bombardieri, M., F. Barone, F. Humby, S. Kelly, M. McGurk, P. Morgan, S. Challacombe, S. De Vita, G. Valesini, J. Spencer, and C. Pitzalis. 2007. Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune si-aloadenitis and MALT lymphoma in Sjogren' s syndrome. J. Immunol. 179:4929-4938.
10. Hsu, H.C., Y. Wu, P. Yang, Q. Wu, G. Job, J. Chen, J. Wang, M.A. Accavitti-Loper, W.E. Grizzle, R.H. Carter, and J.D. Mountz. 2007. Overexpression of activation-induced cytidine deaminase in B cells is associated with production of highly pathogenic autoantibodies. J. Immunol. 178:5357-5365.
11. Jiang, C., J. Foley, N. Clayton, G. Kissling, M. Jokinen, R. Herbert, and M. Diaz. 2007. Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice. J. Immunol. 178:7422-7431.
12. Pasqualucci, L., P. Neumeister, T. Goossens, G. Nanjangud, R.S. Chaganti, R. Kuppers, and R. Dalla-Favera. 2001. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature. 412:341-346.
13. Rabbitts, T.H., A. Forster, P. Hamlyn, and R. Baer. 1984. Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma. Nature. 309:592-597.
14. Rabbitts, T.H., P.H. Hamlyn, and R. Baer. 1983. Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma. Nature. 306:760-765.
15. Pasqualucci, L., R. Guglielmino, J. Houldsworth, J. Mohr, S. Aoufouchi, R. Polakiewicz, R.S. Chaganti, and R. Dalla-Favera. 2004. Expression of the AID protein in normal and neoplastic B cells. Blood. 104:3318-3325.
16. Ramiro, A.R., M. Jankovic, T. Eisenreich, S. Difilippantonio, S. Chen-Kiang, M. Muramatsu, T. Honjo, A. Nussenzweig, and M.C. Nussenzweig. 2004. AID is required for c-myc/IgH chromosome trans-locations in vivo. Cell. 118:431-438.
17. Kuppers, R., and R. Dalla-Favera. 2001. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene. 20:5580-5594.
18. Muschen, M., D. Re, B. J ungnickel, V. Diehl, K. Rajewsky, and R. Kuppers. 2000. Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction. J. Exp. Med. 192:1833-1840.
19. Liu, M., J.L. Duke, D.J. Richter, C.G. Vinuesa, C.C. Goodnow, S.H. Kleinstein, and D.G. Schatz. 2008. Two levels of protection for the B cell genome during somatic hypermutation. Nature. 451:841-845.
20. Okazaki, I.M., H. Hiai, N. Kakazu, S. Yamada, M. Muramatsu, K. Kinoshita, and T. Honjo. 2003. Constitutive expression of AID leads to tumorigenesis. J. Exp. Med. 197:1173-1181.
21. Endo, Y., H. Marusawa, K. Kinoshita, T. Morisawa, T. Sakurai, I.M. Okazaki, K. Watashi, K. Shimotohno, T. Honjo, and T. Chiba. 2007. Expression of activation-induced cytidine deaminase in human hepato-cytes via NF-kappaB signaling. Oncogene. 26:5587-5595.
22. Morgan, H.D., W. Dean, H.A. Coker, W. Reik, and S.K. Petersen-Mahrt. 2004. Activation-induced cytidine deaminase deaminates 5-methyl-cytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming. J. Biol. Chem. 279:52353-52360.
23. Sayegh, C.E., M.W. Quong, Y. Agata, and C. Murre. 2003. E-proteins directly regulate expression of activation-induced deaminase in mature B cells. Nat. Immunol. 4:586-593.
24. Dedeoglu, F., B. Horwitz, J. Chaudhuri, F.W. Alt, and R.S. Geha. 2004. Induction of activation-induced cytidine deaminase gene expression by IL-4 and CD40 ligation is dependent on STAT6 and NFkappaB. Int. Immunol. 16:395-404.
25. Gonda, H., M. Sugai, Y. Nambu, T. Katakai, Y. Agata, K.J. Mori, Y. Yokota, and A. Shimizu. 2003. The balance between Pax5 and Id2 activities is the key to AID gene expression. J. Exp. Med. 198:1427-1437.
26. Butterworth, M., B. McClellan, and M. Allansmith. 1967. Influence of sex in immunoglobulin levels. Nature. 214:1224-1225.
27. Eidinger, D., and T.J. Garrett. 1972. Studies of the regulatory effects of the sex hormones on antibody formation and stem cell differentiation. J. Exp. Med. 136:1098-1116.
28. Li, J., and R.W. McMurray. 2007. Effects of estrogen receptor subtype- selective agonists on autoimmune disease in lupus-prone NZB/NZW F1 mouse model. Clin. Immunol. 123:219-226.
29. Nalbandian, G., and S. Kovats. 2005. Understanding sex biases in immunity: effects of estrogen on the differentiation and function of antigen-presenting cells. Immunol. Res. 31:91-106.
30. Peeva, E., and M. Zouali. 2005. Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes. Immunol. Lett. 101:123-143.
31. Whitacre, C.C. 2001. Sex differences in autoimmune disease. Nat. Immunol. 2:777-780.
32. Hulka, B.S., and A.T. Stark. 1995. Breast cancer: cause and prevention. Lancet. 346:883-887.
33. Shang, Y. 2006. Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis. Nat. Rev. Cancer. 6:360-368.
34. Conticello, S.G., C.J. Thomas, S.K. Petersen-Mahrt, and M.S. Neuberger. 2005. Evolution of the AID/APOBEC family of polynucleo- tide (deoxy)cytidine deaminases. Mol. Biol. Evol. 22:367-377.
35. Tsai, M.J., and B.W. O'Malley. 1994. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63:451-486.
36. Ghosh, M.G., D.A. Thompson, and R.J. Weigel. 2000. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res. 60:6367-6375.
37. Shiau, A.K., D. Barstad, P.M. Loria, L. Cheng, P.J. Kushner, D.A. Agard, and G.L. Greene. 1998. The structural basis of estrogen recep- tor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell. 95:927-937.
38. Auboeuf, D., A. Honig, S.M. Berget, and B.W. O'Malley. 2002. Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science. 298:416-419.
39. Wu, X., J.R. Darce, S.K. Chang, G.S. Nowakowski, and D.F. Jelinek. 2008. Alternative splicing regulates activation-induced cytidine deaminase (AID): Implications for suppression of AID mutagenic activity in normal and malignant B-cells. Blood. 112:4675-4682.
40. Kinoshita, K., M. Harigai, S. Fagarasan, M. Muramatsu, and T. Honjo. 2001. A hallmark of active class switch recombination: transcripts directed by I promoters on looped-out circular DNAs. Proc. Natl. Acad. Sci. USA. 98:12620-12623.
41. Sale, J.E., and M.S. Neuberger. 1998. TdT-accessible breaks are scattered over the immunoglobulin V domain in a constitutively hyper-mutating B cell line. Immunity. 9:859-869.
42. -/- mice. J. Exp. Med. 203:2085-2094.
43. Kotani, A., N. Kakazu, T. Tsuruyama, I.M. Okazaki, M. Muramatsu, K. Kinoshita, H. Nagaoka, D. Yabe, and T. Honjo. 2007. Activation- induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice. Proc. Natl. Acad. Sci. USA. 104:1616-1620.
44. Takizawa, M., H. Tolarova, Z. Li, W. Dubois, S. Lim, E. Callen, S. Franco, M. Mosaico, L. Feigenbaum, F.W. Alt, et al. 2008. AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development. J. Exp. Med. 205:1949-1957.
45. Dorsett, Y., K.M. McBride, M. J ankovic, A. Gazumyan, T.H. Thai, D.F. Robbiani, M. Di Virgilio, B.R. San-Martin, G. Heidkamp, T.A. Schwickert, et al. 2008. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity. 28:630-638.
46. Teng, G., P. Hakimpour, P. Landgraf, A. Rice, T. Tuschl, R. Casellas, and F.N. Papavasiliou. 2008. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity. 28:621-629.
47. Ramiro, A.R., M. Jankovic, E. Callen, S. Difilippantonio, H.T. Chen, K.M. McBride, T.R. Eisenreich, J. Chen, R.A. Dickins, S.W. Lowe, et al. 2006. Role of genomic instability and p53 in AID-induced c-myc- Igh translocations. Nature. 440:105-109.
48. Babbage, G., C.H. Ottensmeier, J. Blaydes, F.K. Stevenson, and S.S. Sahota. 2006. Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines. Cancer Res. 66:3996-4000.
49. Muckenfuss, H., M. Hamdorf, U. Held, M. Perkovic, J. Lower, K. Cichutek, E. Flory, G.G. Schumann, and C. Munk. 2006. APOBEC3 proteins inhibit human LINE-1 retrotransposition. J. Biol. Chem. 281:22161-22172.
50. Cohen-Solal, J.F., V. Jeganathan, C.M. Grimaldi, E. Peeva, and B. Diamond. 2006. Sex hormones and SLE: influencing the fate of autoreactive B cells. Curr. Top. Microbiol. Immunol. 305:67-88.
51. Roy, D., and J.G. Liehr. 1999. Estrogen, DNA damage and mutations. Mutat. Res. 424:107-115.
52. Yager, J.D., and N.E. Davidson. 2006. Estrogen carcinogenesis in breast cancer. N. Engl. J. Med. 354:270-282.
53. Muto, T., I.M. Okazaki, S. Yamada, Y. Tanaka, K. Kinoshita, M. Muramatsu, H. Nagaoka, and T. Honjo. 2006. Negative regulation of activation-induced cytidine deaminase in B cells. Proc. Natl. Acad. Sci. USA. 103:2752-2757.
54. Peeva, E., J. Venkatesh, and B. Diamond. 2005. Tamoxifen blocks estrogen-induced B cell maturation but not survival. J. Immunol. 175:1415-1423.
55. Goodnow, C.C. 2007. Multistep pathogenesis of autoimmune disease. Cell. 130:25-35.
56. Pasqualucci, L., G. Bhagat, M. Jankovic, M. Compagno, P. Smith, M. Muramatsu, T. Honjo, H.C. Morse I II, M.C. Nussenzweig, and R. Dalla-Favera. 2008. AID is required for germinal center-derived lym- phomagenesis. Nat. Genet. 40:108-112.
57. Matsumoto, Y., H. Marusawa, K. Kinoshita, Y. Endo, T. Kou, T. Morisawa, T. Azuma, I.M. Okazaki, T. Honjo, and T. Chiba. 2007. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat. Med. 13:470-476.
58. Liehr, J.G. 1990. Genotoxic effects of estrogens. Mutat. Res. 238:269-276.
59. Bolton, J.L., L. Yu, and G.R. Thatcher. 2004. Quinoids formed from estrogens and antiestrogens. Methods Enzymol. 378:110-123.
60. Cavalieri, E.L., and E.G. Rogan. 2004. A unifying mechanism in the initiation of cancer and other diseases by catechol quinones. Ann. N. Y. Acad. Sci. 1028:247-257.
61. Phillips, D.H. 2001. Understanding the genotoxicity of tamoxifen? Carcinogenesis. 22:839-849.
62. Hodges, L.C., J.D. Cook, E.K. Lobenhofer, L. Li, L. Bennett, P.R. Bushel, C.M. Aldaz, C.A. Afshari, and C.L. Walker. 2003. Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells. Mol. Cancer Res. 1:300-311.
63. Spicer, D.V., M.C. Pike, and B.E. Henderson. 1991. Ovarian cancer and long-term tamoxifen in premenopausal women. Lancet. 337:1414.
64. Harris, R.S., K.N. Bishop, A.M. Sheehy, H.M. Craig, S.K. Petersen- Mahrt, I.N. Watt, M.S. Neuberger, and M.H. Malim. 2003. DNA deamination mediates innate immunity to retroviral infection. Cell. 113:803-809.
65. Petersen-Mahrt, S.K., R.S. Harris, and M.S. Neuberger. 2002. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature. 418:99-103.
66. Gourzi, P., T. Leonova, and F.N. Papavasiliou. 2006. A role for activation-induced cytidine deaminase in the host response against a transforming retrovirus. Immunity. 24:779-786.
67. Vandenbroucke, J. Vandesompele, A.D. Paepe, and L. Messiaen. 2001. Quantification of splice variants using real-time PCR. Nucleic Acids Res. 29:E68.
68. Ausubel, F.M., R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl. 1987. Current Protocols in Molecular Biology. John Wiley & Sons, Inc., Boston.
69. Hatzis, P., and I. Talianidis. 2002. Dynamics of enhancer-promoter communication during differentiation-induced gene activation. Mol. Cell. 10:1467-1477.
70. Kovalchuk, A.L., J.R. Muller, and S. J anz. 1997. Deletional remodeling of c-myc-deregulating chromosomal translocations. Oncogene. 15:2369-2377.
71. Reina-San-Martin, B., S. Difilippantonio, L. Hanitsch, R.F. Masilamani, A. Nussenzweig, and M.C. Nussenzweig. 2003. H2AX is required for recombination between immunoglobulin switch regions but not for intra-switch region recombination or somatic hypermutation. J. Exp. Med. 197:1767-1778.
72. Lumsden, J.M., T. McCarty, L.K. Petiniot, R. Shen, C. Barlow, T.A. Wynn, H.C. Morse III, P.J. Gearhart, A. Wynshaw-Boris, E.E. Max, and R.J. Hodes. 2004. Immunoglobulin class switch recombination is impaired in Atm-deficient mice. J. Exp. Med. 200:1111-1121.